These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2570213)

  • 41. Anti-HCV positive patients in dialysis units?
    Lancet; 1990 Jul; 336(8709):243-4. PubMed ID: 1973787
    [No Abstract]   [Full Text] [Related]  

  • 42. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C virus screening: UK Blood Transfusion Service on the threshold.
    Barbara JA; Contreras M
    Med Lab Sci; 1991 Jul; 48(3):171-4. PubMed ID: 1724056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Donors blood screening and prevention of posttransfusion type C hepatitis in Japan].
    Yoshizawa H
    Uirusu; 1993 Dec; 43(2):315-21. PubMed ID: 7510090
    [No Abstract]   [Full Text] [Related]  

  • 45. [Specific serologic markers of viral hepatitis].
    Darnis F
    Therapie; 1984; 39(5):487-92. PubMed ID: 6506004
    [No Abstract]   [Full Text] [Related]  

  • 46. [Viral hepatitis of the non-A, non-B type in the light of prospective clinical and immunological studies].
    Knap J
    Przegl Epidemiol; 1985; 39(1):1-26. PubMed ID: 3931182
    [No Abstract]   [Full Text] [Related]  

  • 47. Screening blood donations for HCV.
    Maclennan S; Barbara JA; Hewitt P; Moore C; Contreras M
    Lancet; 1992 Jan; 339(8785):131-2. PubMed ID: 1345863
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group.
    Lancet; 1991 Oct; 338(8774):1040-1. PubMed ID: 1681356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody to superoxide dismutase, autoimmune hepatitis, and antibody tests for hepatitis C virus.
    Ikeda Y; Toda G; Hashimoto N; Kurokawa K
    Lancet; 1990 Jun; 335(8701):1345-6. PubMed ID: 1971405
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction].
    Zimmermann R; König V; Bauditz J; Zeiler T; Zingsem J; Heuft HG; Hopf U; Huhn D; Eckstein R
    Beitr Infusionsther; 1992; 30():38-41. PubMed ID: 1284740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant immunoblot assay for hepatitis C virus antibody as predictor of infectivity.
    Ebeling F; Naukkarinen R; Leikola J
    Lancet; 1990 Apr; 335(8695):982-3. PubMed ID: 1970062
    [No Abstract]   [Full Text] [Related]  

  • 53. [Evaluation of screening and complementary tests for anti-HCV antibodies].
    Głoskowska-Moraczewska Z; Kacperska E; Seyfried H
    Acta Haematol Pol; 1993; 24(3):273-80. PubMed ID: 7504386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Epidemiology, clinical aspects and prognosis of viral hepatitis A, B and non-A, non-B].
    Judmaier G
    Acta Med Austriaca Suppl; 1988; 37():1-31. PubMed ID: 3132025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
    Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
    Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infectivity of blood that is immunoblot intermediate reactive on hepatitis C virus antibody testing.
    Bellobuono A; Mozzi F; Petrini G; Zanella A; Sirchia G
    Lancet; 1990 Aug; 336(8710):309. PubMed ID: 1973990
    [No Abstract]   [Full Text] [Related]  

  • 57. Antibodies to hepatitis C virus in French blood donors.
    Janot C; Couroucé AM; Maniez M
    Lancet; 1989 Sep; 2(8666):796-7. PubMed ID: 2571026
    [No Abstract]   [Full Text] [Related]  

  • 58. Non-A, non-B hepatitis viruses.
    Prince AM
    Annu Rev Microbiol; 1983; 37():217-32. PubMed ID: 6314877
    [No Abstract]   [Full Text] [Related]  

  • 59. Antibody to hepatitis C virus in plasma pools.
    Minor P; Pipkin P; Thorpe R; Thomas D
    Lancet; 1990 Jul; 336(8708):188. PubMed ID: 1973512
    [No Abstract]   [Full Text] [Related]  

  • 60. Hepatitis C virus antibodies in parasitic infections.
    Aceti A; Taliani G
    Ann Intern Med; 1990 Oct; 113(7):560. PubMed ID: 2118319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.